A β-sheet peptide inhibitor of E47 dimerization and DNA binding

Chemistry and Biology

Volumn 5, Issue 8, 1998, Pages 439-445

  Ghosh, Indraneel ^a   Chmielewski, Jean ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

BHLH; Dimerization inhibition helix; Peptide; Sheet

Indexed keywords

EID: 0031851117     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(98)90160-0     Document Type: Article

References (35)

1. Broggini, M. & D'Incalci, M. (1994). Modulation of transcription factor-DNA interactions by anticancer drugs. Anti-Cancer Drug Design 9, 373-387.
2. Baguley, B.C. (1991). DNA intercalating antitumor agents, Anti-Cancer Drug Design 6, 1-35.
3. Pindur, U. & Fischer, G. (1996). DNA complexing minor groove-binding ligands: antitumour and antimicrobial drug design. Curr. Med. Chem. 3, 379-406.
4. White, S., Szewczyk, J.W., Turner, J.M., Baird, E.E. & Dervan, P.B. (1998). Recognition of the four Watson-Crick base pairs in the DNA minor groove by synthetic ligands. Nature 391, 468-471.
5. Gewirtz, A.M. (1997). Antisense oligonucleotide therapeutics for human leukemia. Crit. Rev. Oncogenesis 8, 93-109.
6. Maher, J.L. (1992). DNA triple-helix formation-an approach to artificial gene repressors. BioEssays 14, 807-815.
7. Hunziker, J. (1996). Nucleic acid ligands based on carbohydrates. Chimia 391, 468-471.
8. Krylov, D., Kasai, K., Echlin, D.R, Taparowsky, E.J., Arnheiter, H. & Vinson, C. (1997). A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding. Proc. Natl Acad. Sci. USA 94, 12274-12279.
9. Herskowitz, I. (1987). Functional inactivation of genes by dominant negative mutations. Nature 329, 219-222.
10. Zutshi, R., Brickner, M., & Chmielewski, J. (1998). Inhibiting the assembly of protein - protein interfaces. Curr. Opin. Chem. Biol. 2, 62-66.
11. Lenardo, M., Pierce, J.W., & Baltimore, D. (1987). Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility, Science 236, 1573-1577.
12. Look, A.T. (1997). Oncogenic transcription factors in human acute leukemias. Science 278, 1059-1064.
13. Murre, C., McCaw, P.S., & Baltimore, D. (1989). A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56, 777-783.
14. Ellenberger, T., Fass, D., Arnaud, M., & Harrison, S.C. (1994). Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer. Genes Dev. 8, 970-980.
15. Anthony-Cahill, S.J., et al., & DeGrado, W.F. (1992). Molecular characterization of helix-loop-helix peptides. Science 255, 979-983.
16. Murre, C., et al., & Stuiver, M.H. (1994). Structure and function of helix-loop-helix proteins. Biochim. Biophys. Acta. 1218, 129-135.
17. Benezra, R., Davis, R.L., Lokshon, D., Turner, D.L. & Weintraub, H. (1990). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49-59.
18. Langlands, K., Yin, X., Anand, G. & Prochownik, E.V. (1997). Differential Interactions of Id proteins with basic-helix -loop-helix transcription factors. J. Biol. Chem. 272, 19785-19793.
19. Bishop, P., Jones, C., Ghosh, I. & Chmielewki, J. (1995). Synthesis of the basic-helix-loop-helix region of the immunoglobulin enhancer binding protein E47 and evaluation of its structural and DNA binding properties. Int. J. Pept. Protein Res., 46, 149-154.
20. Greenfield, N. & Fasman, G.D. (1969). Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry 8, 4108-4116.
21. Chou, P.Y., & Fasman, G.D. (1974). Prediction of protein conformation. Biochemistry 13, 222-245.
22. Chou, P.Y., & Fasman, G.D. (1974). Conformational parameters for amino acids in helical, β-sheet, and random coil regions calculated from proteins. Biochemistry 13, 211-222.
23. Smith., C.K., Withka, J.M., & Regan, L.A. (1994). Thermodynamic scale for the beta-sheet forming tendencies of the amino-acids. Biochemistry 33, 5510-5517.
24. Minor, D.I., & Kim, P.S. (1994). Context is a major determinant of beta-sheet propensity. Nature 371, 264-267.
25. Mihara, H. & Takahashi, Y. (1997). Engineering peptides and proteins that undergo alpha-to-beta transitions. Curr. Opin. Struct. Biol. 7, 501-508.
26. Ng, S. B. L., & Doig, A. J. (1997). Molecular and chemical basis of prion-related diseases. Chem. Soc. Rev. 26, 425-432.
27. Pan, K.-M., et al., & Prusiner, S.B. (1993). Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl Acad. Sci. USA 90, 10962-10966.
28. Nguyen, J., Baldwin, M.A., Cohen, F.E., & Prusiner S.B. (1995). Prion protein-peptides induce alpha-helix to beta-sheet Conformational transitions. Biochemistry 34, 4186-4192.
29. Minor, D.L. & Kim, P.S. (1996). Context-dependent secondary structure formation of a designed protein sequence. Nature 380, 730-734.
30. Dalal, S., Balasubramanian, S. & Regan, L. (1997). Protein alchemy: Changing beta-sheet into alpha-helix. Nat. Struct. Biol. 4, 548-552.
31. Rink, H., (1987). Solid-phase synthesis of protected peptide fragments using a trialkoxydiphenyl-methylester resin. Tetrahedron Lett. 28, 3787-3790.
32. Atherton, E. & Sheppard, R.C. (1987). In The Peptides. (Gross, E. & Meienhofer, J. eds) Vol. 9, pp 1-38. Academic Press, New York.
33. Bishop, P., Ghosh, I., Jones, C. & Chmielewski, J. (1995). Basic-helix-loop-helix region of Tal: evaluation of structure and DNA affinity. J. Am. Chem. Soc. 117, 8283-8284.
34. Lutgring, R.A., Lipton, M. & Chmielewski, J. (1996). Differential self assembly of amphiphilic helical peptides. Amino Adds 10, 295-304.
35. Shuster, T.M. & Laue, T.M. (1994). Modern Analytical Ultracentrifugation. Birkhauser, Boston.